Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P. Spitzer MS, et al. Among authors: spitzer b. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. doi: 10.1007/s00417-007-0568-7. Epub 2007 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17347807
Safety profile of bevacizumab on cultured human corneal cells.
Yoeruek E, Spitzer MS, Tatar O, Aisenbrey S, Bartz-Schmidt KU, Szurman P. Yoeruek E, et al. Among authors: spitzer ms. Cornea. 2007 Sep;26(8):977-82. doi: 10.1097/ICO.0b013e3180de1d0a. Cornea. 2007. PMID: 17721300
204 results